Valley Forge Scientific Corp. and Synergetics, Inc. Announce Approval By Synergetics Shareholders of Their Merger Transaction
2005年9月19日 - 9:30PM
PRニュース・ワイアー (英語)
KING OF PRUSSIA, Pa. and O'FALLON, Mo., Sept. 19
/PRNewswire-FirstCall/ -- Valley Forge Scientific Corp.
(NASDAQ:VLFG)(BSE:VLF) and Synergetics, Inc., a privately-held
corporation, announced today that the Synergetics shareholders
adopted the merger agreement on Friday, September 16, 2005,
pursuant to which Synergetics will merge with a wholly-owned
subsidiary of Valley Forge and such shareholders will be entitled
to receive, in the aggregate, 15,973,912 shares of Valley Forge
common stock, or approximately 66 percent of the combined company's
outstanding shares on a fully diluted basis. Adoption of the merger
agreement by the Synergetics shareholders satisfies one of the
conditions to the completion of the transaction. Additional
conditions include approval by the shareholders of Valley Forge at
a meeting to be held later today. Synergetics and Valley Forge
expect to close the merger transaction as soon as practicable after
the Valley Forge shareholder meeting, subject to the satisfaction
or waiver of all other closing conditions to the merger. About
Synergetics, Inc. Synergetics designs, manufactures and markets
medical devices for use in ophthalmic surgery and neurosurgery.
Synergetics' products are designed and manufactured to support
micro or minimally invasive surgical procedures. In addition to
Synergetics' surgical devices and equipment, it also designs and
manufactures disposable and non-disposable supplies and accessories
for use with such devices and equipment. Synergetics sells its
products primarily to hospitals, clinics and surgeons in
approximately 70 countries. About Valley Forge Scientific Valley
Forge is a medical device company that develops, manufactures and
sells medical devices for use in surgery and other healthcare
applications. Its core business involves the sale of bipolar
electrosurgical generators and other generators, based on its
DualWave(TM) technology, and complementary instrumentation and
disposable products. Their current line of products is used in
neurosurgery, spine surgery, pain control and in dental
applications. Forward-Looking Statements Some statements in this
release may be "forward-looking statements" for the purposes of the
Private Securities Litigation Reform Act of 1995. In some cases,
forward-looking statements can be identified by words such as
"believe," "expect," "anticipate," "plan," "potential," "continue"
or similar expressions. Such forward-looking statements are based
upon current expectations and beliefs and are subject to a number
of factors. These forward-looking statements are subject to risks
and uncertainties that may cause actual results to differ
materially from those indicated in the forward- looking statements,
including but not limited to: the effects of local and national
economic, credit and capital market conditions on the economy in
general, and on the medical device industry in particular, and the
effects of foreign exchange rates and interest rates; the ability
to obtain or meet the closing conditions in the merger agreement
between Valley Forge and Synergetics, and to otherwise complete the
merger in a timely manner; the ability to timely and
cost-effectively integrate the operations and management of Valley
Forge and Synergetics; the ability to realize the synergies and
other perceived advantages resulting from the merger; the ability
to retain and attract key personnel both before and after the
merger; the ability of each company to successfully execute its
business strategies; the extent and timing of market acceptance of
new products or product indications; the ability of each company to
procure, maintain, enforce and defend its patents and proprietary
know how; changes in laws, including increased tax rates,
regulations or accounting standards, third-party relations and
approvals, and decisions of courts, regulators and governmental
bodies; the ability of the combined company to continue to increase
customer loyalty; the ability to recoup costs of capital
investments through higher revenues; environmental restrictions,
soil and water conditions, weather and other hazards, site access
matters and building permit issues; the effects of environmental
and structural building conditions relating to the combined
company's properties; acts of war or terrorism incidents; the
effects of operating and market competition; and other important
factors disclosed previously and from time to time in the combined
company's filings with the SEC and in the Joint Proxy
Statement/Prospectus filed by Valley Forge and Synergetics with the
SEC. Valley Forge undertakes no obligation to update these
forward-looking statements. VALLEY FORGE SCIENTIFIC CORP.
SYNERGETICS, INC. 3600 Horizon Drive 3845 Corporate Centre Drive
King of Prussia, Pennsylvania, 19406 O'Fallon, Missouri, 63368
(484) 690-9000 (636) 939-5100 http://www.vlfg.com/
http://www.synergeticsusa.com/ Attn: Jerry L. Malis Attn: Pamela G.
Boone, President and CEO Chief Financial Officer DATASOURCE: Valley
Forge Scientific Corp.; Synergetics, Inc. CONTACT: Jerry L. Malis,
President and CEO, Valley Forge Scientific Corp., +1-484-690-9000;
or Pamela G. Boone, Chief Financial Officer, Synergetics, Inc.,
+1-636-939-5100 Web site: http://www.vlfg.com/
http://www.synergeticsusa.com/
Copyright
Valley Forge Scientific (NASDAQ:VLFG)
過去 株価チャート
から 10 2024 まで 11 2024
Valley Forge Scientific (NASDAQ:VLFG)
過去 株価チャート
から 11 2023 まで 11 2024